(Deamino-Cys1,b-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin trifluoroacetate salt
CAS: 136105-89-0
Ref. 3D-FD108862
1mg | 241.00 € | ||
2mg | 393.00 € | ||
5mg | 700.00 € | ||
10mg | 1,067.00 € | ||
25mg | 2,319.00 € |
Product Information
- d(D-3Pal)VP
- [Deamino-Cys1
- D-3-(Pyridyl)Ala2
- Arg8] Vasopressin3-Mercaptopropionyl-?-(3-pyridyl)-D-Ala-Phe-Gln-Asn-Cys-Pro-Arg-Gly -NH2 trifluoroacetate salt (Disulfide bond)
- Argipressin, 1-deamino-3-(3'-pyridyl)-ala(2)-
- 1-Deamino-3-(3'-pyridyl)-2-ala-argipressin
- Argipressin, 1-deamino-3-(3'-pyridyl)alanine(2)-
- d(D-3-Pal)VP
- 1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-6,9,12,15,18-pentaoxo-16-(pyridin-3-ylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-N~5~-(diaminomethylidene)ornithylglycinamide
- 3-Mercaptopropionyl-Beta-3-Pyridyl-D-Ala-Phe-Gln-Asn-Cys-Pro-Arg-Gly-Nh2
- See more synonyms
DDAVP is an analogue of vasopressin, which belongs to the class of inositol phosphates. It is a potent agonist for the V1 receptor and has a higher affinity for this receptor than vasopressin. DDAVP also has antagonist properties at the V2 receptor. The biological activity of DDAVP is mediated by its ability to increase phospholipase A2 activity and cause the release of arachidonic acid from membrane phospholipids. This activation causes an increase in prostaglandin synthesis, leading to increased vascular permeability and hypotension. DDAVP may also have antidiuretic effects due to its antagonism of oxytocin receptors.
Chemical properties
Technical inquiry about: 3D-FD108862 (Deamino-Cys1,b-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin trifluoroacetate salt
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.